Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts

British Journal of Cancer

Volumn 71, Issue 4, 1995, Pages 840-844

  Watson, C J ^a   Miller, W R ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Prolactins; Signal transduction; STAT; Transcriptions factor

Indexed keywords

GAMMA INTERFERON; PROLACTIN; TRANSCRIPTION FACTOR;

ARTICLE; BENIGN TUMOR; BREAST CARCINOMA; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING;

ADENOFIBROMA; BASE SEQUENCE; BINDING SITES; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA IN SITU; CELL NUCLEUS; COMPARATIVE STUDY; DNA-BINDING PROTEINS; FEMALE; HUMAN; HYPERPLASIA; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; SUPPORT, NON-U.S. GOV'T; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0028923658     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.162     Document Type: Article

References (26)

1. AKIRA S, NISHIO Y, INOUEM M, WANG X-J, WEI S, MATSUSAKA T, YOSHIDA K, SUDO T, NARUTO M, AND KISHIMOTO T. (1994). Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gpl30-mediated signalling pathway. Cell, 77, 63–71.
2. BAZAN JF. (1990). Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA, 87, 6934–6938.
3. BURDON TG, MAITLAND KA, CLARK AJ, WALLACE R AND WATSON CJ. (1994a). Regulation of the sheep /Mactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-y activation site (GAS)-related element. Mol. Endocrinol. 8, 1528–1536.
4. BURDON TG, DEMMER J, CLARK AJ AND WATSON CJ. (1994b). The mammary factor MPBF is a prolactin-induced transcriptional regulator which binds to ST AT factor recognition sites. FEBS Lett., 350, 177–182.
5. COUSSENS L, YANG-FENG TL, LIAO YC, CHEN E, GRAY A, MCGRATH J, SEEBURGH PH, LIBERMANN FA, SCHLESSINGER J, FRANCK U, LEVINSON A AND ULLRICH A. (1985). Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, 230, 1132–1139.
6. DARNELL JE, KERR IM AND START GR. (1994). JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science, 264, 1415–1421.
7. DEMMER J, BURDON TG, DJIANE J, WATSON CJ AND CLARK AJ. (1995). The proximal MPBF binding site is required for the prolactin responsiveness of the sheep BLG promoter in CHO cells. Mol. Cell. Endocrinol., 107, 113–121.
8. DIGNAM JD, LEBOVITZ RM AND ROEDER RG. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475–1489.
9. HAPP B, HYNES NE AND GRONER B. (1993). Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor. Cell Growth Different., 4, 9–15.
10. KLIJN JG, BERNS SPM, SCHMITZ PI AND FOEKENS JA. (1992). The clinical significance of EGFR in human breast cancer: a review on 5232 patients. Endocrinol. Rev., 13, 3–17.
11. LEMOINE NR, BARNES DM, HOLLYWOOD DP, HUGHES CM, SMITH P, DUBLIN E, PRIGENT SA, GULLICK WJ AND HURST HC. (1992). Expression of the ERBB3 gene product in breast cancer. Br. J. Cancer, 66, 1116–1121.
12. LIPPMAN ME AND DICKSON RB. (1989). Growth control of normal and malignant breast epithelium. Proc. R. Soc. Edin., 95B, 89–106.
13. MUSS HB, THOR AD, BERRY DA, KUTE T, LIU ET, KOERNER F, CIRRINCIONE CT, BUDMAN DR, WOOD WC AND BARC SM. (1994). C-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast-cancer. N. Engl. J. Med.330 (N18), 1260–1266.
14. PAIKS SM, HAZAN R, FISHER ER et al. (1990). Pathologic findings from the NSABP: Prognostic significance of C-erbB2 protein overexpression in primary breast cancer. J. Clin. Oncol., 8, 103–112.
15. PERREN JJ. (1991). C-erbB2 oncogene as a prognostic marker in breast cancer (editorial). Br. J. Cancer, 63, 328–332.
16. SADOWSKI HB, SHUAI K, DARNELL JE AND GILMAN MZ. (1993). A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science, 261, 1739–1744.
17. SAINSBURY JRC, FARNDEN JR, NEEDHAM GK, MALCOLM AJ AND HARRIS AL. (1987). Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet, i, 1398–1402.
18. SCHMITT-NEY M, DOPPLER W, BALL RK AND GRONER B. (1991). ß-casein gene promoter activity is regulated by the hormonemediated relief of transcriptional repression and a mammary gland-specific nuclear factor. Mol. Cell. Biol., 11, 3745–3755.
19. SCHMITT-NEY M, HAPP B, HOFER P, HYNES N AND GRONER B. (1992). Mol. Endocrinol., 6, 1988–1997.
20. SHUAI K, ZIEMIECKI A, WILKS AF, HARPUR AG SADOWSKI HB, GILMAN MZ AND DARNELL JE. (1993) Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature, 366, 580–583.
21. SHUAI K, HORVATH CM, TSAIHUANG LH QURESHI SA, COW- BURN D AND DARNELL JE. (1994). Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell, 76, 821–828.
22. TOPPER YJ AND FREEMAN CS. (1980). Multiple hormone interactions in the development biology of the mammary gland. Physiol. Rev., 60, 1049–1106.
23. WAKAO H, GOUILLEUX F AND GRONER B. (1994). Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J., 9, 2182–2191.
24. WATSON CJ, GORDON KE, ROBERTSON M AND CLARK AJ. (1991). Interaction of DNA-binding proteins with a milk protein gene promoter in vitro:identification of a mammary gland specific factor. Nucleic Acids Res., 19, 6603–6610.
25. WRIGHT C, NICHOLSON S, ANGUS B, SAINSBURY JRC, FARNDON J, CAIRNS J, HARRIS AL AND HORNE CHW. (1992). Relationship between c-erbB2 protein product expression and response to endocrine therapy in advanced breast cancer. Br. J. Cancer, 65, 118–121.
26. ZHONG Z, WEN Z AND DARNELL JE. (1994) Stat3: a new family member that is activated through tyrosine phosphorylation in response to EGF and IL-6. Science, 264, 95.